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Abstract
Background:  Off-pump coronary artery bypass grafting has been accused of possibly
compromising graft patency. Sixteen slice computed tomography has shown good diagnostic
accuracy in the assessment of coronary bypass graft patency when compared with conventional
coronary artery angiography and is less invasive. The study hypothesis is that coronary artery
bypass grafting (CABG) performed without cardiopulmonary bypass (Off-Pump) has equivalent
early graft patency as if performed with cardiopulmonary bypass (On-Pump) and may have reduced
complication rate.
Methods/Design: The Prospective Randomized Comparison of Off-Pump and On-Pump MultI-
vessel Coronary Artery BypasS Surgery (PROMISS) is a controlled, single blinded, single centre
clinical trial, comparing early graft patency using 16-slice computed tomography in patients with
multi-vessel coronary artery disease operated either without or with extracorporeal circulation.
Inclusion criteria are multivessel disease with an indication for first time, isolated, non emergent
coronary artery bypass grafting with a minimum of three distal anastomoses. Secondary end points
are peri-operative mortality, combined morbidity, length of stay, neuro-cognitive testing at 6 weeks
and adverse events, stress test and quality of life at 6 months and one year. The sample size of one
hundred and fifty patients was calculated in order to enable the detection of a 5% difference in graft
patency, with 80% power, considering a minimum of 3 distal anastomoses per patient. Enrolment
started in April 2005 and ended July 2007 with study closure in July 2008.
Conclusion: The PROMISS trial aims to shed new light on the effect of Off-Pump as compared to
On-Pump coronary artery bypass surgery on graft patency, assessed by multidetector computed
tomography, in unselected patients with multivessel coronary artery disease.
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1. Background
Coronary artery bypass surgery is a proven and effective
mode of treatment for ischaemic heart disease. It provides
relief of symptoms and increases survival, in particular in
patients with left main disease and two or three vessel dis-
ease including the proximal left anterior descending artery
[1].
Coronary artery bypass grafting (CABG) can be performed
in several ways but in the majority of cases it is still per-
formed with the assistance of cardiopulmonary bypass
(CPB), aortic cross clamping and cardioplegia induced
cardiac arrest ("on-pump" or conventional method). Cor-
onary artery bypass grating can also be performed without
CPB ("off-pump" or OPCAB) and this method's applica-
tion varies from around 20% in the USA and Europe to
more than 50% in India and Japan.
As a consequence of increased life expectancy and a more
widespread use of coronary angiography with exponential
growth of percutaneous coronary interventions in ischae-
mic heart disease, patients proposed for CABG are older
and suffer from more co-morbid conditions. In spite of
this, continuous incremental improvements in peri-oper-
ative patient management, anaesthetic and surgical tech-
niques have led to better results [2]. However, morbidity
is still significant in certain patient subsets and off-pump
coronary artery bypass surgery saw its development in the
nineties with the rationale of reducing some of the cardi-
opulmonary bypass related complications [3]. Indeed,
although CPB is usually well tolerated in the majority of
cases, it can be responsible for complications and death,
particularly in older and sicker patients with co-morbid
conditions. Cardiopulmonary bypass may be a source of
distal embolization by aortic canulation and manipula-
tion and causes myocardial ischaemia-reperfusion injury
through cardioplegic arrest. CPB causes also a systemic
inflammatory response and increases the need for blood
transfusion by hemodilution and coagulation distur-
bances [4].
Most studies show that OPCAB is associated with less car-
diac, pulmonary, renal or neurologic complications and
reduces blood transfusion and hospital stay compared
with "on-pump" coronary bypass surgery [5-7]. However,
there is still some debate about the type and degree of
morbidity reduction achieved by OPCAB [8]. For exam-
ple, neurocognitive decline is one of the most frequent
sequelae of cardiac surgery but there is still no consensus
whether OPCAB is superior to conventional CABG with
respect to this complication [8]. Neuropsychological eval-
uation is based on a battery of tests evaluating memory,
learning, attention, psychomotor speed, dexterity and
diverging results between studies, may be due to different
assessment protocols, different timings, statistical tools
used to define a decline and absence of control groups.
In general, there has been difficulty in accumulating scien-
tific evidence for OPCAB benefit, due to low incidence of
events (mortality, stroke, myocardial infarction), there-
fore requiring very large samples or high risk populations
to demonstrate a statistically significant improvement [9].
On the other hand, "off-pump" CABG has been accused
of compromising completeness of revascularisation and
graft patency by its increased technical difficulty, particu-
larly in grafting the left ventricular lateral wall [10].
Indeed, a learning curve applies in OPCAB, and its bene-
fits can be expected only with the strict application of
principles and rules and a sustained practice without
which results can be inferior to those obtained with con-
ventional "on-pump" CABG. The same applies to long
term results which depend on completeness and quality
of revascularisation.
Coronary artery bypass grafting has an important role in
the treatment of coronary artery disease as shown by series
with long term results [11]. However, increased survival
and symptoms relief are directly related to graft patency.
Consequently, it is important that new, less invasive
methods reduce the early risk of the procedure but also
ensure the same revascularisation quality as the conven-
tional technique.
The justification for theProspective Randomized Compar-
ison of Off-Pump and On-Pump MultI-vessel Coronary
Artery BypasS Surgery (PROMISS) derives from current
discordant data in the literature regarding the potential
inferior graft patency when CABG is performed off-pump
as compared with the arrested heart on-pump procedure
[12-15]. There would be no advantage to the patient if a
short term benefit was to be compromised by the ultimate
goal of achieving perfect myocardial revascularisation. In
fact, while some studies show no difference in graft pat-
ency, others show decreased graft permeability when
OPCAB is used [12-15].
Many procedural and surgeon related factors (exposure,
stabilisation, shunt use, operator's experience and patient
selection) can account for these differences so it is impor-
tant to evaluate both off and on-pump coronary bypass
surgery using standardised techniques, unbiased assess-
ment of results and an accurate patency control method.
Until recently, coronary angiography was the only
method to assess coronary artery bypass graft patency.
This technique is stressful, causes discomfort and has local
(limb ischemia, haematoma, false aneurysm), neurologi-
cal (stroke, TIA) and cardiac (graft dissection, myocardialTrials 2008, 9:44 http://www.trialsjournal.com/content/9/1/44
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infarction, arrhythmias) complications in up to 1% of
cases [16]. From an ethical standpoint, a potential life
threatening complication risk in asymptomatic patients
discouraged us from embarking on a randomized study
using conventional coronary angiography.
Recent advances in multidetector computed tomography
(MDCT) technology, namely with reduced acquisition
time and improved spatial resolution, has permitted its
application to the detection of coronary artery disease and
bypass graft evaluation [17]. Relative graft immobility and
freedom from calcification allows multidetector com-
puted tomography to achieve high diagnostic accuracy for
coronary bypass graft patency evaluation [18-20]. This led
to the design of a randomized but non invasive study of
coronary bypass graft patency, comparing on and off-
pump techniques and the conception of PROMISS.
PROMISS primary objective is to compare early coronary
bypass graft patency by 16 slice computed tomography in
patients with multivessel coronary artery disease undergo-
ing first time coronary artery bypass grafting with (on-
pump) and without (off-pump) cardiopulmonary bypass.
Secondary endpoints are:
1- Mortality and morbidity in patients operated with on-
pump and off-pump.
2- Comparative changes in neuro-cognitive performance
between base line and 4–6 weeks by a battery of neuropsy-
chological tests.
3- Evaluation of functional status, ischaemic threshold by
stress test, quality of life and adverse events at 6 months
and one year.
Finally, as tertiary end point we aim to analyse hospital
costs.
2. Methods
PROMISS is a prospective, randomized, single blinded,
single centre study.
2.1 Organization
Patient inclusion, surgery, post operative care, multidetec-
tor computed tomography and follow-up are conducted
at Hospital da Cruz Vermelha Portuguesa. The principal
investigator designed the study and is the surgeon respon-
sible for performing all on-pump and off-pump opera-
tions. The principal investigator has a large experience in
on-pump CABG and has performed more than 300
OPCAB surgeries before initiating the study.
2.2 Ethical Issues
PROMISS is registered in The International Society for
Clinical Randomized Trials (ISRCTN58800729), it is con-
ducted in accordance with the principles of The Declara-
tion of Helsinki, with the Portuguese laws and rules and
subscribes to the principles outlined in the International
Conference on Harmonisation of Good Clinical Practice
[21].
All patients receive full explanation of study objectives,
the operations to be performed, with or without CPB
according to randomization, its risks and benefits and
signed the informed consent form.
Any death during the study period requires the hospital
ethical commission to be informed.
2.3 Recruiting Process
All patients that comply with the inclusion and exclusion
criteria are considered for enrolment in PROMISS (Table
1). Inclusion requires consensus between two surgeons
regarding the operative plan: number of grafts with at least
three distal anastomoses and target vessels to bypass. This
operative plan is then recorded in the patient's case report
form before the operation.
No patient is excluded because of recent myocardial inf-
arction, ventricular dysfunction, or poor quality target ves-
sels (size, location, calcification). No patient is excluded
for associated morbid conditions with the exception of
renal insufficiency (because of iodine administration)
and atrial fibrillation (multidetector computed tomogra-
phy imperative).
Table 1: Eligibility Criteria
Inclusion Exclusion
Multivessel CAD IV inotropes, IABP, Assisted Ventilation
First Time CABG with ≥ 3 grafts Associated Surgical Procedure
Age 30–90 years Creatinin > 1.5 ULN
Signed Informed Consent Chronic Atrial Fibrillation
Iodine Allergy
Non Menopaused Woman
Inability to Give Informed ConsentTrials 2008, 9:44 http://www.trialsjournal.com/content/9/1/44
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During the study period, a patient diagram flow is used
indicating patients screened, patients enrolled and rea-
sons for exclusion, patients randomized and patients
available for MDCT and follow up according to the CON-
SORT recommendations (Figure 1) [22].
2.4 Randomization
The informed consent is signed before randomization.
Randomization is performed by the method of random
permuted blocks. A sealed envelope containing the
patient's number is opened in the operating room before
the beginning of the operation.
2.5 "Cross-over" and study discontinuation
Cross-over from one group to another is possible in case
patient safety is deemed at risk, a condition that is esti-
mated to occur in less than 5% of the cases:
￿ From on-pump to off-pump group in case of calcified
ascending aorta.
￿ From the off-pump to the on-pump group in case of
refractory hemodynamic deterioration.
Patients who cross over from off-pump to on-pump are
analysed in the original off-pump group for which he or
she was randomized in intent to treat analysis.
Premature exit from the study is possible at any moment
at patient's will or because of inclusion/exclusion criteria
violation.
2.6 Surgical technique and post operative care
Premedication, anaesthetic protocol, patient opening and
closing, harvesting and graft anastomoses techniques are
the same in both groups.
Study Flow Chart Figure 1
Study Flow Chart.
Assessed for eligibility
(n=196)
Excluded  (n=46)
Not meeting inclusion criteria (n=15) 
Refused to participate (n=5)
Logistics (n=8 )
Creatinin>1.5 ULN (n=6)
Atrial Fibrillation (n=2)
Other reasons (n=10)
Analyzed  (n=    )
Excluded from analysis  (n=     )
Reasons
Lost to follow-up  (n=    )
Reasons
Discontinued intervention
(n= )
Reasons
Allocated to intervention OFF PUMP
(n=75)
Received allocated intervention
(n=74)
Did not receive allocated intervention
(n=1)
Reasons: mitral regurgitation 
requiring mitral valve surgery 
replacement
Lost to follow-up  (n=    )
Reasons
Discontinued intervention
(n= )
Reasons
Analyzed  (n=    )
Excluded from analysis  (n=     )
Reasons
Allocation
Analysis
Enrollment
Randomization
(n=150)
Study Flow Chart
Follow-Up
Allocated to intervention ON-PUMP
(n=75)
Received allocated intervention
(n=72)
Did not receive allocated intervention
(n=3) 
Reasons:  Conversion to Off-Pump due to 
porcelain aorta (n=2); Mitral valve 
replacement (n=1)Trials 2008, 9:44 http://www.trialsjournal.com/content/9/1/44
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On-pump CABG uses a conventional roller pump cardi-
opulmonary bypass machine with an arterial filter, con-
tinuous ultra filtration, and a central temperature that is
allowed to drift to 34°C. Myocardial protection is pro-
vided by 34°C antegrade blood-potassium cardioplegia
delivered every 25 minutes.
Off-pump coronary artery bypass grafting uses a deep
pericardial stitch and vacuum stabilizers for exposure.
Intra coronary shunts are systematically used.
The planned/performed distal anastomoses index and the
reason for eventual incomplete revascularisation as well
as target coronary artery quality (scale 1–4) are noted in
the two groups.
Post operative care is under the responsibility of the same
intensive care team and follows the rules and protocols of
the hospital ICU.
2.7 Blinding
Treatment group is blinded to patients, family and inves-
tigators responsible for the MDCT angiographic control,
neuro-psychological tests and follow-up.
2.8 Data Collection
Demographic data, pre operative, intra operative, post
operative and follow up variables are reported in a dedi-
cated Case Report Form. Event adjudication is made by
hospital physicians according to standardized definitions
(Table 2). Protocol adherence and data collection reliabil-
ity are monitored by an independent external body verify-
ing conformity with good clinical practice requisites
(EuroTrials, Scientific Consultants, Lisbon, Portugal).
2.9 Assessment of results
a/ Principal end point
The study main end point, comparison of graft patency at
4 to 6 weeks between the two groups, is performed by a
GE Lightspeed 16 slice multidetector computed tomogra-
phy using a standard protocol already described [23]. A
cardiologist and a radiologist, with previous knowledge of
the number and distribution of grafts performed but not
the technique that was used assess the grafts using multi-
plane reformatted images, maximal intensity projection
images and three dimensional reconstructions. Quality
image is graded as good/excellent, minor artefacts, mod-
erate artefacts and major artefacts. Only good/excellent
images and images with minor artefacts are considered for
analysis.
Each graft is independently graded using a three grade
scale: occluded graft, graft stenosis of 50% or more, and
stenosis < 50% or no stenosis at proximal anastomoses (if
any), body graft and distal anastomosis [23].
Graft occlusion is defined as absence of contrast material
along the course of the graft, through the graft anastomo-
sis to the native coronary artery or to the following graft
segment and native vessel. In sequential bypass grafts,
each anastomosis of one graft is counted as a separate
graft. The overall graft score is the worst of the three subc-
sores. Graft patency is evaluated according to graft mate-
rial, site, as well as number of anastomoses patent per
patient.
b/ Secondary endpoints
Secondary end points are:
Table 2: Definition of Post Operative Events
Outcome Definition
Mortality Autopsy result.
Arrythmias Episodes requiring administration of iv anti arrythmics or electric choc. Atrio-ventricular conduction disturbances 
defined as requiring temporary or definitive pace maker.
Reoperation Reoperation or recatheterisation for myocardial ischemia.
Myocardial Infarction New Q wave or increase in CK-MB > 5xULN.or troponin T > or = 1 ng/ml.
CK-MB and troponin T Mean values at 6, 12 and 24 hours post operatively.
Cardiac Faillure Cardiac resuscitation manoeuvres or intra aortic balloon pump. Level of inotropic support.
Neurologic Events Coma (Glasgow score), stroke (focal neurologic deficit > 24 hours), transient ischemic attack (focal neurologic 
deficit < 24 hours), delirium.
Respiratory Complications ARDS, ventilation > 24 hours, pneumonia, thoracic effusion or pneumothorax requiring drainage and PaO2 at 
discharge from ICU.
Renal Complications Renal dialysis, ultra filtration, need for continuous iv diuretics, serum creatinin increase between base line and 
ICU discharge.
Bleeding Complications Reoperation for bleeding, blood products administration, total blood drainage.
Infectious Complications Sternal infection (deep and superficial); septicaemia.
Gastro Intestinal Complications Cholecystitis, Pancreatitis, Mesenteric Ischaemia, GI perforation, GI bleeding, Intestinal Occlusion.
Ressource utilisation Readmision to ICU; ICU and hospital length of stay.Trials 2008, 9:44 http://www.trialsjournal.com/content/9/1/44
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1- Revascularisation index: number of planned distal
anastomoses/number of performed distal anastomoses.
2- Adverse events at hospital discharge and at 4–6 weeks
(Table 2). Each complication is separately analysed, Major
adverse events rate is also recorded as the cumulative inci-
dence of mortality, myocardial infarction, stroke or TIA,
dialysis, reoperation for ischemia, ventilation > 24 h.
3- Neuro-cognitive assessment
Neurocognitive assessment consisted on the performance
at baseline and at 4–6 weeks of the following tests:
￿ Digit span (from Wechsler Adult Intelligence Scale-III)
￿ Digit Symbol (from Wechsler Adult Intelligence Scale -
III)
￿ Grooved pegboard test
￿ Auditory verbal learning test
￿ Complex Figure Test
￿ Trail making test A and B
￿ Letter Word Fluency
￿ Controlled Oral Word Association (COWA)
￿ Hospital Anxiety Depression Scale (HADS)
￿ Beck Depression Inventory
The assessment of 50 healthy demographically matched
control subjects, with the same test battery and test-re-test
procedures, will enable the calculation of T -scores for
each neuropsychological evaluation. Decline will be
defined by a drop equal or greater to 15 points.
4- Follow up at 6 months and 1 year will compare func-
tional status, stress test, adverse events and quality of life
by EuroQOL between the two groups.
c/ Tertiary end point
is the analysis of costs: direct patient care related in hospi-
tal costs.
2.10. Statistical analysis
a/ Sample size
PROMISS was planned as a non inferiority study of one
intervention (OPCAB) relative to the reference operation
(on-pump). This study was designed with adequate power
(80%; α level of 0.05) to detect an absolute difference in
patency rates between groups in either direction as small
as 5%. The calculation resulted in a total of 426 units (dis-
tal graft anastomoses). Since each patient has by the inclu-
sion criteria at least 3 grafts, 71 patients in each group are
necessary (213 grafts) for a total of 142 patients. Consid-
ering the possibility of 4 patients' withdrawal in each
group, a total sample of 150 patients was established.
b/ Statistical analysis
Discrete data are presented as numbers and percentages;
continuous data are presented as median, mean (SD) and
compared using t test or the Mann-Whitney test. Dichoto-
mous morbidity and mortality outcomes are analyzed
using the Fisher exact test. Ordered categorical outcomes
are compared between groups using the Mantel Haenszel
χ2.
Dichotomous patency outcomes or graft stenosis > 50%
are analyzed using the Fisher exact test. Mean number of
patent anstomosis per patient is compared using the t test
or the Mann-Whitney test.
3. Discussion
The Prospective Randomized Comparison of Off-Pump
and On-Pump MultI-vessel Coronary Artery BypasS Sur-
gery (PROMISS) was designed to try to answer the ques-
tion of whether or not coronary artery bypass grafting
performed off-pump has the same early graft patency as if
performed on-pump in arrested hearts.
The sample size was calculated in order to detect a +/- 5%
difference between the two techniques. This trial includes
only patients with multi vessel disease with an indication
to perform at least 3 distal coronary artery anastomoses
for two reasons. Firstly to compare the two techniques in
terms of completeness of revascularisation since various
series have reported a lower number of grafts/patient in
OPCAB relative to conventional on-pump surgery [8].
Secondly to compare OPCAB graft patency with the refer-
ence method in a high percentage of cases requiring revas-
cularisation of the lateral wall for its reported increased
technical difficulty [24,25]. Complete revascularisation is
mandatory including the lateral wall since it is one reason
for the superior outcomes of CABG compared with percu-
taneous coronary intervention [26,27].
Few studies have compared OPCAB versus CABG with
CPB among randomly assigned patients unselected for
coronary anatomy, ventricular function or co-morbidities
except renal insufficiency. All surgeries using standardized
techniques were performed by a single surgeon experi-
enced with both methods in an attempt to eliminate tech-
nical variability.Trials 2008, 9:44 http://www.trialsjournal.com/content/9/1/44
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This is the first randomized study comparing early graft
patency in off-pump and on-pump coronary bypass sur-
gery using 16 slice multidetector computed tomography
in patients with multivessel disease. Although 64 slice
multidetector computed tomography has improved tem-
poral and spatial resolution, there is ample evidence that,
with appropriate heart rate reduction, 16 slice MDCT is
able to accurately detect graft occlusion and stenosis com-
pared to conventional coronary angiography [23,28,29].
Limitations of this study include the fact that physicians
involved in patient care, except those assessing graft pat-
ency, are not blinded to treatment method, which can
eventually bias treatment decision making and length of
stay. Another limitation is the single surgeon type of study
which may prevent generalizability of the results. Finally,
the assumption made for sample size calculation that
graft patency within a patient is an independent research
unit may not always apply requiring application of statis-
tical adjustment.
Conclusion
The Prospective Randomized Study of graft patency in
Off-pump and On-pump MultI-Vessel coronary artery
bypasS Surgery (PROMISS) using multidetector com-
puted tomography, has the potential to shed new light on
the ongoing debate regarding these two techniques and
therefore may have implications on the revascularisation
strategy.
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